Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
High prevalence of hepatitis C in Egyptian patients with chronic liver disease.
1995
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Targeted Therapy in Breast Cancer
2004
Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
2014
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis
2013
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Oxidative stress, aging, and diseases
2018 Standout
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
2005
Emerging and Re-emerging Infectious Diseases
2000
Hepatocellular carcinoma
2016 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
1999
Genetic Epidemiology of Hepatitis C Virus throughout Egypt
2000
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
BILE ACID TRANSPORT
1999
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
The Role of Hepatitis C in Hepatocellular Carcinoma
2001
EGF–ERBB signalling: towards the systems level
2006 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Bayesian Coalescent Inference of Past Population Dynamics from Molecular Sequences
2005 Standout
Regulation of cancer cell metabolism
2011 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
2008
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
2008
Hepatitis C Epidemiology
2000
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
2013
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan
2004
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Children with hepatitis C
2002
The tumor microenvironment and metastatic disease
2008
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Identification of a Locus for Progressive Familial Intrahepatic Cholestasis PFIC2on Chromosome 2q24
1997
Breast cancer metastasis: markers and models
2005 Standout
Children with hepatitis C
2002
Hepatitis viruses: changing patterns of human disease.
1994
Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns
2001
γ‐Synuclein and the progression of cancer
2007
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
2008
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
The Interleukin-8 Pathway in Cancer
2008 Standout
Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in Chemoprevention
2011
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Immune responses to plasmid DNA encoding the hepatitis C virus core protein
1995 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Melatonin: reducing the toxicity and increasing the efficacy of drugs
2002
The role of interleukin-8 in cancer cells and microenvironment interaction
2005
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
2008 Standout
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
2009
Works of Ali Khalifa being referenced
Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
2002
Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children
1995
Prevalence of Hepatitis C Viral Antibody in Transfused and Nontransfused Egyptian Children
1993
Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer
1999
Regulators of apoptosis in human breast cancer
1999
Cis-platinum–induced immunosuppression: relationship to melatonin in human peripheral blood mononuclear cells
1999
Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-α
2001
Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients
2004
Comparative Evaluation of the Nuclear Matrix Protein, Fibronectin, Urinary Bladder Cancer Antigen and Voided Urine Cytology in the Detection of Bladder Tumors
2002
The Epidemiology of Antibody to Hepatitis C in Egypt
1993
Quantitative measurement of c-erbB-2 p185 and mutant p53 expression in ovarian neoplasms by enzyme immunoassay
1996